he last few years have seen an increase in product recalls. For this and other reasons, the U.S. FDA come under increasing negative public scrutiny.
High profile drug recalls, food chain problems and contamination, import problems, resignations. Now a new commissioner vows no more "business as usual"
High profile drug recalls, food chain problems and contamination, import problems, resignations. Now a new commissioner vows no more "business as usual"
